The International Consortium for Innovation and Quality in Pharmaceutical Development (IQ) is a technically-focused organization of pharmaceutical and biotechnology companies with a mission of advancing science-based and scientifically-driven standards and regulations for pharmaceutical and biotechnology products worldwide.
		
IQ provides a sustained forum for the exchange of ideas within and across technical disciplines in these industries. The Consortium is leading initiatives in the areas of chemistry, manufacturing and control; preclinical safety; drug metabolism; clinical pharmacology; quality; and the reduction, refinement, and replacement of animal testing. As part of these initiatives, which are managed by Leadership Groups and Working Groups, members lead and participate in collaborative research, industry surveys and benchmarking exercises.
		
IQ is also partnering with governmental bodies, other trade groups, and academic researchers. Through publications, scientific conferences, workshops and roundtables, the Consortium shares the results of its work and facilitates constructive scientific exchange.

IQ Consortium

Philip Floyd

This department focuses on the strategies and practices related to the safe and effective use of medications based on pharmacokinetics and pharmacodynamics.

Clinical Pharmacology

This department oversees the strategic direction and governance of the consortium's initiatives and groups.

IQ Consortium

Org chart

Teams

Clinical Pharmacology

Consortium Leadership

Offices

IQ Consortium

Org chart

Teams

Clinical Pharmacology

Consortium Leadership

Offices

Related companies